Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases

OBJECTIVE: This paper prospectively evaluates the long-term follow-up [mean ± standard deviation (SD) duration: 89.7±19.4 months] data of 15 patients (13 females and 2 males) with refractory symptomatic immune thrombocytopenia (ITP) treated with rituximab. MATERIALS AND METHODS: Rituximab was admini...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Turk J Haematol
Prif Awduron: Hindilerden, Fehmi, Yönal-Hindilerden, İpek, Yenerel, Mustafa Nuri, Nalçacı, Meliha, Diz-Küçükkaya, Reyhan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Galenos Publishing 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5451692/
https://ncbi.nlm.nih.gov/pubmed/27102929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.2016.0086
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg